- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT01817595
Evaluation of Iphone Technology in Diabetes Treatment
Background
With the emergence of the internet, health care professionals are changing the way they approach diabetes management. Internet Blood Glucose Monitoring Systems (IBGMS) are aimed at keeping blood glucose levels normal or in the range of acceptable levels to prevent the complications associated with diabetes. The Principal Investigators have completed a randomized clinical trial supporting the efficacy of IBGMS (1,2).
Patient satisfaction of reporting platform is essential to encourage patient reporting and participation in IBGMS. In this study, we wish to compare two different types of meters which will be used to internet blood glucose monitoring: the BG Star Meter (Conventional Meter), and the iBG Star Group (iPhone Technology).
Purpose and Rationale
Patients who are more satisfied with their meter and internet reporting platform are more likely to participate in an internet monitoring system. Patients often lack the motivation to report to their endocrinologist. With increased reporting to their healthcare professional, patients are more likely to benefit from such a system. This study aims to compare two types of meters and their respective internet reporting platforms to encourage patient participation.
Objectives
Our main goal is to compare the two types of meters.
Primary Outcomes Include:
- Patient Satisfaction as measured by the "Diabetes Treatment Satisfaction Questionnaire" (DTSQ)
- Frequency of reporting to endocrinologist
- Number of Self-Monitoring Blood Glucose (SMBG) tests
- Time taken to teach each patient the platforms
Research Design/Methods
Sample Size: 50 patients will be randomized into two groups:
BG Star Group (Conventional Meter) 25 patients will use the (conventional) BG star meter in which patients will upload their readings onto a computer and send in their readings via email.
IBG Star Group (iPhone Technology) 25 patients will be randomized to the iBGstar system will upload their readings to their iPhone and send in their readings using the iPhone.
Patients will be recruited from a Physician's private office.
Both the (Conventional meter) BG star and iBG star (iPhone Technology) group will be asked to perform SMBG 3 or more times per day and to upload their metered glucose values online every 2 weeks to be reviewed by the doctor.
Inclusion criteria:
- Type 1s
- Type 2s, can be on insulin, oral antihyperglycemic agents, or in combination.
- Willingness to test blood glucose levels a minimum of 3 times daily
- Willingness to be randomized
- Trained in self-blood glucose monitoring
- Internet Access
Exclusion criteria: Patients who do not meet the above criteria or are not willing to participate will not be included in the study.
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
Background/Hypothesis
Management of diabetes is an evolving challenge to health care professionals. The fluctuations of glucose levels over the lifetime of patients with diabetes can lead to complications such as nephropathy, neuropathy, retinopathy and cardiovascular diseases. Although diabetes is a chronic disease, it can be controlled with use of medications (oral agents or insulin), and/or changes in life-style and diet.
With the emergence of the internet, health care professionals are changing the way they approach diabetes management. Internet Blood Glucose Monitoring Systems (IBGMS) are aimed at keeping blood glucose levels normal or in the range of acceptable levels to prevent the complications associated with diabetes. The Principal Investigators have completed a randomized clinical trial supporting the efficacy of IBGMS (1,2).
Patient satisfaction of reporting platform is essential to patient reporting and participation in IBGMS. In this study, we wish to compare two different types of meters which will be used to internet blood glucose monitoring: the BG Star Meter (Conventional Meter), and the iBG Star Group (iPhone Technology).
Purpose and Rationale
Patients who are more satisfied with their meter and internet reporting platform are more likely to participate in an internet monitoring system. Patients often lack the motivation to report to their endocrinologist. With increased reporting to their healthcare professional, patients are more likely to benefit from such a system. This study aims to compare two types of meters and their respective internet reporting platforms to encourage patient participation.
Objectives
Our main goal is to compare the two types of meters.
Primary Outcomes Include:
- Patient Satisfaction as measured by the "Diabetes Treatment Satisfaction Questionnaire" (DTSQ)
- Frequency of reporting to endocrinologist
- Number of Self-Monitoring Blood Glucose (SMBG) tests
- Time taken to teach each patient the platforms
Research Design/Methods
Sample Size: 50 patients will be randomized into two groups:
BG Star Group (Conventional Meter) 25 patients will use the (conventional) BG star meter in which patients will upload their readings onto a computer and send in their readings via email.
IBG Star Group (iPhone Technology) 25 patients will be randomized to the iBGstar system will upload their readings to their iPhone and send in their readings using the iPhone.
Patients will be recruited from a Physician's private office.
Both the (Conventional meter) BG star and iBG star (iPhone Technology) group will be asked to perform SMBG 3 or more times per day and to upload their metered glucose values online every 2 weeks to be reviewed by the doctor.
Inclusion criteria:
- Type 1s
- Type 2s, can be on insulin, oral antihyperglycemic agents, or in combination.
- Willingness to test blood glucose levels a minimum of 3 times daily
- Willingness to be randomized
- Trained in self-blood glucose monitoring
- Internet Access
Exclusion criteria: Patients who do not meet the above criteria or are not willing to participate will not be included in the study.
Confidentiality According to the guidelines of the University of British Columbia (UBC)/Providence Health Care Research Ethics Boards, the identity of participants will be kept confidential.
Data for each patient will be collected from the Clinical Research Coordinator and the Internet based glucose monitoring system. These data will only be accessed by the investigators and will be inputted into an Excel® spreadsheet where each patient will be given a unique identifier. All data pertaining to individual patients will be kept locked in the office of the study investigators.
Calculations and Statistics Statistical analysis will be performed on site by the researchers. Each group will complete the DTSQ. Questions revolve around satisfaction of treatment and are to be answered on a scale of 1 (very dissatisfied) to 6 (very Satisfied). Frequency of reporting will be determined through number of reports sent in per month. Total strip count will be recorded for each group. Time will be measured for the time it takes to train each patient in their respective meter/platform. All outcome measurements will be analysed using independent samples t-tests. Participants will only be identified by coded initials and a number to protect privacy.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6E1M7
- Endocrine Research Society
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Type 1s
- Type 2s, can be on insulin, oral antihyperglycemic agents, or in combination.
- Willingness to test blood glucose levels a minimum of 3 times daily
- Willingness to be randomized
- Trained in self-blood glucose monitoring
- Internet Access
Exclusion Criteria:
Patients who do not meet the above criteria or are not willing to participate will not be included in the study.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Terapia di supporto
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: BG Star (Conventional Meter)
25 patients will use the (conventional) BG star meter in which patients will upload their readings onto a computer and send in their readings via email.
|
Patients in BG Star Meter Group will report using BG software through uploading information onto a computer and sending readings to their endocrinologist via email
|
|
Comparatore attivo: IBG Star Group (iPhone)
25 patients will be randomized to the iBGstar system will upload their readings to their iPhone and send in their readings using the iPhone.
|
25 patients will be randomized to the iBGstar system will upload their readings to their iPhone and send in their readings using the iPhone.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Soddisfazione del paziente
Lasso di tempo: 6 mesi
|
6 mesi
|
|
|
Frequency of SMBG testing
Lasso di tempo: 6 months
|
6 months
|
|
|
Frequency of Reporting
Lasso di tempo: 6 months
|
How often patient sends report in to endocrinologist
|
6 months
|
|
Time required to teach meter/internet platform
Lasso di tempo: Measured at beginning of study
|
Measured at beginning of study
|
Collaboratori e investigatori
Sponsor
Pubblicazioni e link utili
Collegamenti utili
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- IBG star study
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .